PMM2-CDG

Advertisement

cGxPJobs Banner

Glycomine Advances GLM101 Into Phase 2b Rare Disease Trial

SAN CARLOS, Calif., April 2, 2026 Glycomine, Inc. has announced the successful completion of patient enrollment in its global...

By cGxPwire Editor
April 3, 2026

Read More

Advertisement

cGxPJobs

Directory